FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

11429711000001107: Cabergoline 2mg tablets (Unichem Plc) 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
41063401000001118 Cabergoline 2mg tablets (Unichem Plc) 20 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
54635601000001116 Cabergoline 2mg tablets (Alliance Healthcare (Distribution) Ltd) 20 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Is a Cabergoline 2mg tablets 20 tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Is pack of Cabergoline 2mg tablets (Unichem Plc) false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has active ingredient Cabergoline false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has AMP Cabergoline 2mg tablets (Unichem Plc) true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has specific active ingredient Cabergoline true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cabergoline 2mg tablets (Unichem Plc) 20 tablet Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start